Quarterly report · Q2
7730.TEDINET S100QLQK
Period2022-09-01 → 2023-02-28
Filed2023-04-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥12.0bn | 2022-09-01 → 2023-02-28 | Cons. | Net sales |
| Revenue | ¥20.4bn | 2021-09-01 → 2022-08-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥9.7bn | 2021-09-01 → 2022-02-28 | Cons. | Net sales |
| Operating income | ¥3.5bn | 2022-09-01 → 2023-02-28 | Cons. | Operating income |
| Operating income | ¥3.1bn | 2021-09-01 → 2022-02-28 | Cons. | Operating income |
| Ordinary income | ¥3.5bn | 2022-09-01 → 2023-02-28 | Cons. | Ordinary income |
| Ordinary income | ¥7.5bn | 2021-09-01 → 2022-08-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.4bn | 2021-09-01 → 2022-02-28 | Cons. | Ordinary income |
| Profit before tax | ¥3.6bn | 2022-09-01 → 2023-02-28 | Cons. | Income before income taxes |
| Profit before tax | ¥3.4bn | 2021-09-01 → 2022-02-28 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.6bn | 2022-09-01 → 2023-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥5.3bn | 2021-09-01 → 2022-08-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.3bn | 2021-09-01 → 2022-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥2.6bn | 2022-09-01 → 2023-02-28 | Cons. | Profit loss |
| Net income | ¥2.3bn | 2021-09-01 → 2022-02-28 | Cons. | Profit loss |
| Total assets | ¥50.7bn | at 2023-02-28 | Cons. | Assets |
| Total assets | ¥50.1bn | at 2022-08-31 | Cons. | Assets |
| Total assets | ¥44.3bn | at 2022-02-28 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥4.6bn | at 2023-02-28 | Cons. | Liabilities |
| Total liabilities | ¥4.7bn | at 2022-08-31 | Cons. | Liabilities |
| Net assets / equity | ¥46.2bn | at 2023-02-28 | Cons. | Net assets |
| Net assets / equity | ¥45.4bn | at 2022-08-31 | Cons. | Net assets |
| Net assets / equity | ¥41.0bn | at 2022-02-28 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥23.4bn | at 2023-02-28 | Cons. | Cash and deposits |
| Cash and deposits | ¥22.7bn | at 2022-08-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥21.4bn | at 2023-02-28 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥22.1bn | at 2022-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥18.2bn | at 2022-02-28 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥18.1bn | at 2021-08-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥3.8bn | 2022-09-01 → 2023-02-28 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥6.6bn | 2021-09-01 → 2022-08-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥3.0bn | 2021-09-01 → 2022-02-28 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥2.6bn | 2022-09-01 → 2023-02-28 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.2bn | 2021-09-01 → 2022-08-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.0bn | 2021-09-01 → 2022-02-28 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥1.8bn | 2022-09-01 → 2023-02-28 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥2.4bn | 2021-09-01 → 2022-08-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.2bn | 2021-09-01 → 2022-02-28 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥26.04 | 2022-09-01 → 2023-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.84 | 2022-12-01 → 2023-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥53.75 | 2021-09-01 → 2022-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.71 | 2021-09-01 → 2022-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥10.27 | 2021-12-01 → 2022-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 91.0% | at 2023-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.6% | at 2022-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 92.5% | at 2022-02-28 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 32
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-09-01 → 2023-02-28 | −¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-09-01 → 2023-02-28 | −¥1m |
| jpcrp040300-q2r_E02340-000Dentalreportable segment | revenue | 2022-09-01 → 2023-02-28 | ¥4.7bn |
| jpcrp040300-q2r_E02340-000Dentalreportable segment | revenue external | 2022-09-01 → 2023-02-28 | ¥4.7bn |
| jpcrp040300-q2r_E02340-000Dentalreportable segment | segment profit | 2022-09-01 → 2023-02-28 | ¥1.3bn |
| jpcrp040300-q2r_E02340-000Eyeless Needlereportable segment | revenue | 2022-09-01 → 2023-02-28 | ¥4.2bn |
| jpcrp040300-q2r_E02340-000Eyeless Needlereportable segment | revenue external | 2022-09-01 → 2023-02-28 | ¥4.2bn |
| jpcrp040300-q2r_E02340-000Eyeless Needlereportable segment | revenue intersegment | 2022-09-01 → 2023-02-28 | ¥1m |
| jpcrp040300-q2r_E02340-000Eyeless Needlereportable segment | segment profit | 2022-09-01 → 2023-02-28 | ¥1.3bn |
| jpcrp040300-q2r_E02340-000Surgicalreportable segment | revenue | 2022-09-01 → 2023-02-28 | ¥3.2bn |
| jpcrp040300-q2r_E02340-000Surgicalreportable segment | revenue external | 2022-09-01 → 2023-02-28 | ¥3.2bn |
| jpcrp040300-q2r_E02340-000Surgicalreportable segment | segment profit | 2022-09-01 → 2023-02-28 | ¥917m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-09-01 → 2023-02-28 | ¥12.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-09-01 → 2023-02-28 | ¥12.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-09-01 → 2023-02-28 | ¥1m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-09-01 → 2023-02-28 | ¥3.5bn |
| Reconciling Itemsreconciling | revenue | 2021-09-01 → 2022-02-28 | −¥2m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-09-01 → 2022-02-28 | −¥2m |
| jpcrp040300-q2r_E02340-000Dentalreportable segment | revenue | 2021-09-01 → 2022-02-28 | ¥4.0bn |
| jpcrp040300-q2r_E02340-000Dentalreportable segment | revenue external | 2021-09-01 → 2022-02-28 | ¥4.0bn |
| jpcrp040300-q2r_E02340-000Dentalreportable segment | segment profit | 2021-09-01 → 2022-02-28 | ¥1.3bn |
| jpcrp040300-q2r_E02340-000Eyeless Needlereportable segment | revenue | 2021-09-01 → 2022-02-28 | ¥2.9bn |
| jpcrp040300-q2r_E02340-000Eyeless Needlereportable segment | revenue external | 2021-09-01 → 2022-02-28 | ¥2.9bn |
| jpcrp040300-q2r_E02340-000Eyeless Needlereportable segment | revenue intersegment | 2021-09-01 → 2022-02-28 | ¥2m |
| jpcrp040300-q2r_E02340-000Eyeless Needlereportable segment | segment profit | 2021-09-01 → 2022-02-28 | ¥782m |
| jpcrp040300-q2r_E02340-000Surgicalreportable segment | revenue | 2021-09-01 → 2022-02-28 | ¥2.8bn |
| jpcrp040300-q2r_E02340-000Surgicalreportable segment | revenue external | 2021-09-01 → 2022-02-28 | ¥2.8bn |
| jpcrp040300-q2r_E02340-000Surgicalreportable segment | segment profit | 2021-09-01 → 2022-02-28 | ¥973m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-09-01 → 2022-02-28 | ¥9.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-09-01 → 2022-02-28 | ¥9.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-09-01 → 2022-02-28 | ¥2m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-09-01 → 2022-02-28 | ¥3.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 533
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任 あずさ監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)宮 木 直 哉 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)筑 紫 徹 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 9651000000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 12025000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 20416000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 3390000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 3512000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 7544000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 2333000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 2563000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 5290000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 2985000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 2394000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 8574000000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 41007000000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 46179000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 45414000000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 44330000000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 50745000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 50113000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 23.71 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 26.04 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 53.75 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.925 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.910 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.906 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | 3008000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | 3838000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 6559000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | -2011000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -2643000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -2173000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | -1219000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | -1826000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -2444000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 18205000000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 21358000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 22084000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | 10.27 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | 12.84 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 106973352 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 106973352 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 106973352 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 106973352 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |